Publications

Beigene Medical Europa

A phase 2, multicenter, single-arm of Zanubrutinib

 Back View
A phase 2, multicenter, single-arm of Zanubrutinib
 PDF   1   06/2020
 View

Trial in progress: A phase 2, multicenter, single-arm of Zanubrutinib (BGB-3111) in patients with previously treated B-Cell Malignancies intolerant of prior treatment of Ibrutinib or Acalabrutinib

Related publications

Zanubrutinib - Mode of Action
Zanubrutinib - Mode of Action
ASPEN: Results of a Phase 3 Randomized Trial of Zanubrutinib versus Ibrutinib for Patients with Waldenström Macroglobulinemia (EHA)
ASPEN: Results of a Phase 3 Randomized Trial of Zanubrutinib versus Ibrutinib for Patients with Waldenström Macroglobulinemia (EHA)
Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL
Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL
 Back

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service